1. Antinori, A and Giancola, M and Grisetti, S and Soldani, F and Alba, L and Liuzzi, G and Amendola, A and Capobianchi, M and Tozzi, V and Perno, C. (2002) Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients AIDS, 16, pp. 1867 - 1876. [INFOTRIEVE][CSA]
2. Benton, A.(1974) Revised Visual Retention Test: clinical and experimental applications, 4th ed.. New York : Psychological Corp.
3. Brambilla, D and Jennings, C and Morack, R and Granger, S and Bremer, J. (2004) Comparison of the sensitivities of the version 1.5 and version 1.0 ultrasensitive Roche AMPLICOR HIV-1 MONITOR kits at low concentrations of human immunodeficiency virus RNA J Clin Micro, 42, pp. 2819 - 2820. [CSA][CROSSREF]
4. Brenneman, D and Hauser, J and Spong, C and Phillips, T and Pert, C and Ruff, M. (1999) VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 gp120-induced neuronal death Brain Res, 838, pp. 27 - 36. [INFOTRIEVE][CSA][CROSSREF]
5. Brew, B and Pemberton, L and Ray, J. (2004) Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs? J NeuroVirol, 10(Suppl 1), pp. 38 - 43. [INFOTRIEVE][CSA][CROSSREF]